作者: Amany M. Gad , Ola M. Abd El-Raouf , Bahia M. El-Sayeh , Hala M. Fawzy , Dalaal M. Abdallah
DOI: 10.1002/JBT.21979
关键词:
摘要: Renal toxicity is one of the most severe complications that can occur with cisplatin (CIS) administration in cancer patients. Montelukast (ML) renoprotective outcome contrary to CIS-drawn nephrotoxicity remains obscure. Therefore, adult male Sprague-Dawley rats were orally given ML (10 and 20 mg/kg/day) 5 days before after single CIS (5 mg/kg; i.p.) treatment. returned blood urea nitrogen, as well serum creatinine gamma glutamyl transferase elevated by normal level. The improved kidney function tests corroborated attenuation renal injury at microscopical It also reduced serum/renal nitric oxide hemeoxygenase-1. Meanwhile, hindered raised levels endothelin-1, tumor necrosis factor-α, monocyte chemoattractant protein-1. These effects associated deceased caspase-3 expression In conclusion, guards against CIS-induced via anti-inflammatory antiapoptotic properties.